World J Hepatol 20157204-12.Shavakhi A Minakari M Firouzian H Assali R Hekmatdoost A Ferns G. Effect of a probiotic and metformin on liver aminotrans- ferases in non-alcoholic steatohepatitis a double blind randomized clinical trial.

Semin Liver Dis 20072744-54.Ghaemi A Taleban FA Hekmatdoost A Rafiei A Hosseini V Amiri Z Homayounfar R Fakheri H. How much weight loss is effective on nonalcoholic fatty liver disease Hepat Mon 201313e15227.Schnabl B Brenner DA.

World J Gastroenterol 2015218787-803.Qin J Li Y Cai Z Li S Zhu J Zhang F Liang S Zhang W Guan Y Shen D et al.

J Nutr 20001301314-9.Birt DF Boylston T Hendrich S Jane JL Hollis J Li L McClelland J Moore S Phillips GJ Rowling M et al.

J Hepatol 200747711-7.Araya J Rodrigo R Videla LA Thielemann L Orellana M Pettinelli P Poniachik J.

J Nutr Biochem 200920657-62.Askari F Rashidkhani B Hekmatdoost A. Cinnamon may have therapeutic benefits on lipid profile liver enzymes insulin resistance and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.

Adv Nutr 20178240-52.Keywords nonalcoholic fatty liver disease gut microbiota diet NAFLD NASH probioticsIntroductionNonalcoholic fatty liver disease NAFLD6 is the most com- mon cause of chronic liver diseases in the world 1.

Con- sidering that the anatomy of the liver facilitates a close inter- action between the liver and gut microbiome it is possible that gut microbial metabolites and circulating byproducts influence liver function.

ISME J 201610321-32.Maslowski KM Vieira AT Ng A Kranich J Sierro F Yu D Schilter HC Rolph MS Mackay F Artis D et al.

J Hepatol 2008 48983-92.Busserolles J Gueux E Rock E Demigne C Mazur A Rayssiguier Y. Oligofructose protects against the hypertriglyceridemic and pro- oxidative effects of a high fructose diet in rats.

